[When should anti-TNF-alpha treatment in Crohn disease be terminated?].
Gastroenterologisk avdeling Oslo universitetsykehus, Aker 0514 Oslo. bjorn.moum@medisin.uio.no
Bjørn
B
Moum
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003424:Crohn Disease / Q000188:drug therapy*; D006801:Humans; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha
Når bør anti-TNF-alpha-behandling ved Crohns sykdom avsluttes?